Intraoperative Detection of Cancer Tissue in Pancreatic Adenocarcinoma Using a VEGF-targeted Optical Fluorescent Imaging Tracer, A Multicentre Feasibility Dose Escalation Study
Phase of Trial: Phase I/II
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Pancreatic cancer
- Focus Diagnostic use
- Acronyms PENGUIN
- 25 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 25 Oct 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
- 27 Sep 2016 Status changed from not yet recruiting to recruiting.